Insiders · TTOO

TTOO insider transactions

T2 Biosystems Inc. (TTOO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TTOO insiders

Everyone who has filed a Form 4 or 5 at T2 Biosystems Inc., latest first. Follow anyone to get their next filing.

• Seymour LiebmanDirector
• Brett A. GiffinChief Commercial Officer+$5,183-$3,015
• Laura Lee AdamsDirector
• John W CummingDirector-$21.1K
• Michael Terrence GibbsGeneral Counsel+$4,900-$31.1K
• Ninfa SaundersDirector
• Robin ToftDirector
• John J Sperzel IIIOfficer, Director+$15K-$6,179
• David B ElsbreeDirector-$133
• John M SpragueCFO+$4,767-$12.4K
• CR Group L.P.10% owner-$12.9M
• Thierry BernardDirector
• Alec BarclayOfficer+$6,476-$38.2K
• Aparna AhujaOfficer-$29.8K
• Goldman Sachs & Co. LLC10% owner+$29.8K-$25.7K
• Adrian M JonesDirector+$29.8K-$25.7K
• John McDonoughDirector-$21.1K
• Anthony PareOfficer-$17.7K

Recent Form 3, 4, and 5 filings for TTOO

• 673d
  SEC Form 4 filed by Director Liebman Seymour

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Chief Commercial Officer Giffin Brett A.

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Director Adams Laura Lee

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Director Cumming John W

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by General Counsel Gibbs Michael Terrence

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Director Saunders Ninfa

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Director Toft Robin

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Officer Sperzel John J Iii

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by Director Elsbree David B

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 673d
  SEC Form 4 filed by CFO Sprague John M

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 780d
  Director Elsbree David B sold $133 worth of shares (55 units at $2.42), decreasing direct ownership by 71% to 23 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 907d
  Cr Group L.P. converted options into 1,824,800 shares (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 913d
  Cr Group L.P. was granted 4,748,335 shares (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 933d
  Cr Group L.P. was granted 3,280,618 shares (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 983d
  Sperzel John J Iii converted options into 67 shares, increasing direct ownership by 20% to 400 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 983d
  Gibbs Michael Terrence converted options into 29 shares, increasing direct ownership by 27% to 135 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 983d
  Sprague John M converted options into 29 shares, increasing direct ownership by 26% to 141 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 990d
  Gibbs Michael Terrence converted options into 40 shares, increasing direct ownership by 61% to 106 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 990d
  Sperzel John J Iii converted options into 160 shares, increasing direct ownership by 92% to 333 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 990d
  Sprague John M converted options into 40 shares, increasing direct ownership by 56% to 112 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 990d
  Giffin Brett A. converted options into 13 shares, increasing direct ownership by 20% to 77 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 994d
  Cr Group L.P. converted options into 824,220 shares (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1038d
  SEC Form 4 filed by Toft Robin

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1074d
  Giffin Brett A. converted options into 33 shares, increasing direct ownership by 106% to 64 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1074d
  Giffin Brett A. converted options into 1,333 shares and sold $349 worth of shares (537 units at $0.65), increasing direct ownership by 35% to 3,049 units (SEC Form 4) (Amendment)

  4/A - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1113d
  Adams Laura Lee converted options into 7 shares, increasing direct ownership by 23% to 37 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Elsbree David B converted options into 2,300 shares, increasing direct ownership by 42% to 7,824 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Toft Robin converted options into 2,300 shares, increasing direct ownership by 66% to 5,772 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Saunders Ninfa converted options into 2,300 shares, increasing direct ownership by 46% to 7,322 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Cumming John W converted options into 2,600 shares, increasing direct ownership by 98% to 5,256 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Adams Laura Lee converted options into 2,300 shares, increasing direct ownership by 314% to 3,032 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Liebman Seymour converted options into 2,300 shares, increasing direct ownership by 49% to 7,002 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1122d
  Bernard Thierry converted options into 2,300 shares, increasing direct ownership by 46% to 7,322 units (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1134d
  Cr Group L.P. sold $2,271,957 worth of shares (13,130,147 units at $0.17) (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1135d
  Cr Group L.P. sold $1,082,359 worth of shares (5,392,920 units at $0.20) (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1136d
  Cr Group L.P. sold $62,500 worth of shares (250,000 units at $0.25) (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1137d
  Cr Group L.P. sold $1,314,534 worth of shares (5,079,344 units at $0.26) (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1137d
  Cr Group L.P. sold $1,904,632 worth of shares (6,338,211 units at $0.30) (SEC Form 4)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1141d
  SEC Form 4: Cr Group L.P. sold $2,408,302 worth of shares (7,753,710 units at $0.31)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1142d
  SEC Form 4: Cr Group L.P. sold $3,806,937 worth of shares (10,401,466 units at $0.37)

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1178d
  SEC Form 4: Bernard Thierry converted options into 2,004 shares, increasing direct ownership by 66% to 5,022 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1178d
  SEC Form 4: Toft Robin converted options into 454 shares, increasing direct ownership by 15% to 3,472 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1178d
  SEC Form 4: Saunders Ninfa converted options into 2,004 shares, increasing direct ownership by 66% to 5,022 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1211d
  SEC Form 4 filed by Cr Group L.P. (Amendment)

  4/A - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1219d
  SEC Form 4 filed by Cr Group L.P.

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1219d
  SEC Form 3 filed by new insider Cr Group L.P.

  3 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1310d
  SEC Form 4 filed by Gibbs Michael Terrence

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1311d
  SEC Form 4 filed by Gibbs Michael Terrence (Amendment)

  4/A - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1319d
  SEC Form 4 filed by Gibbs Michael Terrence

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1338d
  SEC Form 4: Sprague John M converted options into 6,914 shares and sold $1,682 worth of shares (2,693 units at $0.62) as part of a pre-agreed trading plan, increasing direct ownership by 139% to 7,268 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1338d
  SEC Form 4: Giffin Brett A. converted options into 1,333 shares and sold $349 worth of shares (537 units at $0.65) as part of a pre-agreed trading plan, increasing direct ownership by 1,769% to 841 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1338d
  SEC Form 4: Adams Laura Lee converted options into 732 shares

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1338d
  SEC Form 4: Gibbs Michael Terrence converted options into 6,914 shares and sold $2,329 worth of shares (3,730 units at $0.62) as part of a pre-agreed trading plan, increasing direct ownership by 96% to 6,517 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1338d
  SEC Form 4: Sperzel John J Iii converted options into 22,667 shares and sold $6,179 worth of shares (9,773 units at $0.63) as part of a pre-agreed trading plan, increasing direct ownership by 291% to 17,329 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1445d
  SEC Form 4: Giffin Brett A. converted options into 3,333 shares and sold $2,317 worth of shares (1,292 units at $1.79), increasing direct ownership by 963% to 2,253 units

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1485d
  SEC Form 4 filed by Liebman Seymour

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1485d
  SEC Form 4 filed by Saunders Ninfa

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1485d
  SEC Form 4 filed by Elsbree David B

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1485d
  SEC Form 4 filed by Adams Laura Lee

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)
• 1485d
  SEC Form 4 filed by Toft Robin

  4 - T2 Biosystems, Inc. (0001492674) (Issuer)